LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
6.40
+0.09 (1.43%)
At close: Nov 14, 2025, 4:00 PM EST
6.41
+0.01 (0.16%)
After-hours: Nov 14, 2025, 5:23 PM EST
LifeStance Health Group Market Cap
LifeStance Health Group has a market cap or net worth of $2.49 billion as of November 14, 2025. Its market cap has decreased by -4.45% in one year.
Market Cap
2.49B
Enterprise Value
2.76B
1-Year Change
-4.45%
Ranking
Category
Stock Price
$6.40
Market Cap Chart
Since the IPO on June 10, 2021, LifeStance Health Group's market cap has decreased from $6.73B to $2.49B, a decrease of -62.98%. That is a compound annual growth rate of -20.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 2.49B | -11.72% |
| Dec 31, 2024 | 2.82B | -4.87% |
| Dec 29, 2023 | 2.96B | 59.61% |
| Dec 30, 2022 | 1.86B | -47.85% |
| Dec 31, 2021 | 3.56B | -47.04% |
| Jun 10, 2021 | 6.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |